Literature DB >> 1408505

Severe retinopathy of prematurity and steroid exposure.

D G Batton1, C Roberts, M Trese, M J Maisels.   

Abstract

During a 3-year period (1988 through 1990) an increase was observed in the number of infants born at 23- to 26-weeks' gestation who required cryotherapy for severe retinopathy of prematurity (0/20, 1988; 3/14, 1989; 6/18, 1990; P = .015). Inasmuch as this was not related to improved survival, a retrospective case-control study was conducted to try to explain this observation. Of 52 surviving infants who had been born at 23 to 26 weeks' gestation, 9 required cryotherapy and the other 43 served as control subjects. There were no differences between groups in birthweight, gestational age, or the number of infants with hyaline membrane disease, intraventricular hemorrhage, or hydrocephalus. Factors related to the need for cryotherapy included patent ductus arteriosus (P = .046), mechanical ventilation for more than 21 days (P = .045), and the use of steroids for lung disease (P < .001). In this neonatal intensive care unit, steroids are administered according to the attending neonatologist's preference. Inasmuch as steroids are considered only for infants still ventilator dependent at 21 days, this group was analyzed separately (n = 36). Of the 21 factors examined, only the use of steroids for lung disease was associated with the need for cryotherapy (P < .001).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1408505

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

Review 1.  Pharmacologic interventions for the prevention and treatment of retinopathy of prematurity.

Authors:  Kay D Beharry; Gloria B Valencia; Douglas R Lazzaro; Jacob V Aranda
Journal:  Semin Perinatol       Date:  2016-01-29       Impact factor: 3.300

2.  Ophthalmological morbidity in very-low-birthweight infants with bronchopulmonary dysplasia.

Authors:  O A Ajayi; D Raval; N Lucheese; R S Pildes
Journal:  J Natl Med Assoc       Date:  1997-10       Impact factor: 1.798

Review 3.  Dexamethasone therapy in chronic lung disease.

Authors:  S Sardesai; M Durand
Journal:  Indian J Pediatr       Date:  1996 Jan-Feb       Impact factor: 1.967

4.  Dopamine use is an indicator for the development of threshold retinopathy of prematurity.

Authors:  M B Mizoguchi; T G Chu; F M Murphy; N Willits; L S Morse
Journal:  Br J Ophthalmol       Date:  1999-04       Impact factor: 4.638

Review 5.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

6.  Retinopathy of prematurity and risk factors: a prospective cohort study.

Authors:  Padmani Karna; Jyotsna Muttineni; Linda Angell; Wilfried Karmaus
Journal:  BMC Pediatr       Date:  2005-06-28       Impact factor: 2.125

7.  New Predictors for Advanced Retinopathy of Prematurity among Neonates in Tehran/Iran.

Authors:  Karim Poorsattar Bejeh Mir; Parisa Mohagheghi; Arash Poorsattar Bejeh Mir; Seyed-Mohammad Fereshtehnejad
Journal:  Iran J Pediatr       Date:  2012-09       Impact factor: 0.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.